Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$64.78
+3.90%
Mkt Cap $411.79M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
Implied Upside
+77.5%
Consensus $115.00 vs current $64.78
NASDAQ·Healthcare·Biotechnology
$64.78
+3.90%
Mkt Cap $411.79M
Buy
5
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
+77.5%
Consensus $115.00 vs current $64.78